Article Information
History
- April 30, 2021.
Article Versions
- Version 1 (April 30, 2021 - 04:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Jin Gaoa,
- Laura Klenowa,
- Lisa Parsonsb,
- Tahir Malika,
- Je-Nie Phuec,
- Zhizeng Gaod,
- Stephen G. Withersd,
- John Cipollob,
- Robert Danielsa,* and
- Hongquan Wana,*
- aDivision of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD
- bDivision of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD
- cFacility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD
- dDepartment of Chemistry, University of British Columbia, Vancouver, Canada
- ↵Correspondence to: Robert Daniels: Robert.daniels{at}fda.hhs.gov; Hongquan Wan: Hongquan.wan{at}fda.hhs.gov.